10-Q Filing

BIO-TECHNE CORP CIK: 842023 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0001437749-21-011348`
Period End Date	20210331
Filing Date	20210507
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	tech20210331_10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 97 Income Statement 100 Cash Flow Statement 82

Balance Sheet 97 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$1.43M	USD	Point-in-time
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$775.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$146.62M	USD	Point-in-time
Undesignated capital stock, no par (in dollars per share)	`UndesignatedCapitalStockNoParValue`	-	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$186.14M	USD	Point-in-time
Undesignated capital stock, no par (in dollars per share)	`UndesignatedCapitalStockNoParValue`	-	USD	Point-in-time
Undesignated capital stock, shares authorized (in shares)	`UndesignatedCapitalStockSharesAuthorized`	5.00M	shares	Point-in-time
Undesignated capital stock, shares authorized (in shares)	`UndesignatedCapitalStockSharesAuthorized`	5.00M	shares	Point-in-time
Short-term available-for-sale investments	`AvailableForSaleSecuritiesCurrent`	$90.11M	USD	Point-in-time
Short-term available-for-sale investments	`AvailableForSaleSecuritiesCurrent`	$124.27M	USD	Point-in-time
Undesignated capital stock, shares issued (in shares)	`UndesignatedCapitalStockSharesIssued`	0.00	shares	Point-in-time
Undesignated capital stock, shares issued (in shares)	`UndesignatedCapitalStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net of $1,428 and $775 of reserves, respectively	`AccountsReceivableNetCurrent`	$122.53M	USD	Point-in-time
Accounts receivable, net of $1,428 and $775 of reserves, respectively	`AccountsReceivableNetCurrent`	$157.79M	USD	Point-in-time
Inventories	`InventoryNet`	$109.99M	USD	Point-in-time
Undesignated capital stock, shares outstanding (in shares)	`UndesignatedCapitalStockSharesOutstanding`	0.00	shares	Point-in-time
Undesignated capital stock, shares outstanding (in shares)	`UndesignatedCapitalStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$103.15M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$22.58M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$24.34M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$520.92M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$566.61M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	38.45M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$176.83M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$198.97M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	38.85M	shares	Point-in-time
Right of use asset	`OperatingLeaseRightOfUseAsset`	$71.83M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	38.45M	shares	Point-in-time
Right of use asset	`OperatingLeaseRightOfUseAsset`	$71.47M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	38.85M	shares	Point-in-time
Goodwill	`Goodwill`	$746.46M	USD	Point-in-time
Goodwill	`Goodwill`	$728.31M	USD	Point-in-time
Goodwill	`Goodwill`	$728.31M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$516.54M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$489.18M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$13.52M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$11.59M	USD	Point-in-time
Total assets	`Assets`	$2.08B	USD	Point-in-time
Total assets	`Assets`	$2.03B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$23.09M	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$25.84M	USD	Point-in-time
Salaries, wages and related accruals	`EmployeeRelatedLiabilitiesCurrent`	$31.09M	USD	Point-in-time
Salaries, wages and related accruals	`EmployeeRelatedLiabilitiesCurrent`	$43.27M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$15.69M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$9.09M	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$18.71M	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$13.05M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$2.38M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$3.56M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$10.41M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$9.54M	USD	Point-in-time
Contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$5.94M	USD	Point-in-time
Contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$5.07M	USD	Point-in-time
Current portion of long-term debt obligations	`LongTermDebtCurrent`	$12.50M	USD	Point-in-time
Current portion of long-term debt obligations	`LongTermDebtCurrent`	$12.50M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	-	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$2.58M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$137.64M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$106.67M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$101.09M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$98.40M	USD	Point-in-time
Long-term debt obligations	`LongTermDebtAndCapitalLeaseObligations`	$202.93M	USD	Point-in-time
Long-term debt obligations	`LongTermDebtAndCapitalLeaseObligations`	$344.24M	USD	Point-in-time
Long-term contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$7.10M	USD	Point-in-time
Long-term contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$199.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$67.25M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$66.82M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$23.81M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$26.95M	USD	Point-in-time
Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding	`UndesignatedCapitalStockValue`	-	USD	Point-in-time
Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding	`UndesignatedCapitalStockValue`	-	USD	Point-in-time
Common stock, par value $.01 per share; authorized 100,000,000; issued and outstanding 38,854,000 and 38,453,046, respectively	`CommonStockValue`	$385.00K	USD	Point-in-time
Common stock, par value $.01 per share; authorized 100,000,000; issued and outstanding 38,854,000 and 38,453,046, respectively	`CommonStockValue`	$389.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$420.54M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$514.30M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.09B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.06B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-64.02M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-97.20M	USD	Point-in-time
Total Bio-Techne shareholders' equity	`StockholdersEquity`	$1.54B	USD	Point-in-time
Total Bio-Techne shareholders' equity	`StockholdersEquity`	$1.38B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	-	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$8.49M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.53B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.55B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.44B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.17B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.32B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.17B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.29B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.38B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$2.08B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$2.03B	USD	Point-in-time

Income Statement 100 line items

Line Item	Tag	Value	Unit	Period
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$562.86M	USD	3 Qtrs
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$243.55M	USD	1 Quarter
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$194.68M	USD	1 Quarter
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$672.00M	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$75.28M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$192.98M	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$64.62M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$215.10M	USD	3 Qtrs
Gross margin	`GrossProfit`	$168.27M	USD	1 Quarter
Gross margin	`GrossProfit`	$130.06M	USD	1 Quarter
Gross margin	`GrossProfit`	$456.91M	USD	3 Qtrs
Gross margin	`GrossProfit`	$369.88M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$82.60M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$203.36M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$66.32M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$238.31M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$48.41M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$17.05M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$49.88M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$15.95M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$288.19M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$251.77M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$99.65M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$82.27M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$118.11M	USD	3 Qtrs
Operating income	`OperatingIncomeLoss`	$68.63M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$168.71M	USD	3 Qtrs
Operating income	`OperatingIncomeLoss`	$47.79M	USD	1 Quarter
Other (expense) income	`NonoperatingIncomeExpense`	$-27.65M	USD	3 Qtrs
Other (expense) income	`NonoperatingIncomeExpense`	$-970.00K	USD	1 Quarter
Other (expense) income	`NonoperatingIncomeExpense`	$96.84M	USD	3 Qtrs
Other (expense) income	`NonoperatingIncomeExpense`	$-23.27M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$45.35M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$46.82M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$141.06M	USD	3 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$214.95M	USD	3 Qtrs
Income taxes	`IncomeTaxExpenseBenefit`	$16.12M	USD	3 Qtrs
Income taxes	`IncomeTaxExpenseBenefit`	$44.50M	USD	3 Qtrs
Income taxes	`IncomeTaxExpenseBenefit`	$-48.00K	USD	1 Quarter
Income taxes	`IncomeTaxExpenseBenefit`	$10.39M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$45.40M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$36.43M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$14.40M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$170.45M	USD	3 Qtrs
Net earnings, including noncontrolling interest	`ProfitLoss`	$33.40M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$119.62M	USD	1 Quarter
Net earnings, including noncontrolling interest	`ProfitLoss`	$124.94M	USD	3 Qtrs
Net earnings, including noncontrolling interest	`ProfitLoss`	$46.14M	USD	1 Quarter
Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-380.00K	USD	1 Quarter
Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-509.00K	USD	3 Qtrs
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$125.45M	USD	3 Qtrs
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$36.43M	USD	1 Quarter
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$45.78M	USD	1 Quarter
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$170.45M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$27.70M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-15.14M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-19.40M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-1.14M	USD	1 Quarter
Derivative instruments - cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$5.49M	USD	3 Qtrs
Derivative instruments - cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$-5.70M	USD	1 Quarter
Derivative instruments - cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$-4.80M	USD	3 Qtrs
Derivative instruments - cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$1.29M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-19.94M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$146.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$33.19M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$18.99M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$14.06M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-25.11M	USD	1 Quarter
Other comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Other comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$14.00K	USD	3 Qtrs
Other comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$-69.00K	USD	1 Quarter
Other comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Other comprehensive income attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-25.11M	USD	1 Quarter
Other comprehensive income attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$215.00K	USD	1 Quarter
Other comprehensive income attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-8.11M	USD	1 Quarter
Other comprehensive income attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$13.28M	USD	1 Quarter
Other comprehensive income attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-19.94M	USD	3 Qtrs
Other comprehensive income attributable to Bio-Techne	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$33.18M	USD	3 Qtrs
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$46.00M	USD	1 Quarter
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$158.63M	USD	3 Qtrs
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$11.33M	USD	1 Quarter
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$150.51M	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.18	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.24	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$4.46	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.95	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$4.33	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.12	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.92	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.11	USD	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	38.86M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	38.30M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	38.69M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	38.17M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	39.44M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	39.35M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	40.30M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	40.68M	shares	1 Quarter

Cash Flow Statement 82 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$45.40M	USD	1 Quarter
Net earnings	`ProfitLoss`	$36.43M	USD	1 Quarter
Net earnings	`ProfitLoss`	$14.40M	USD	1 Quarter
Net earnings	`ProfitLoss`	$170.45M	USD	3 Qtrs
Net earnings	`ProfitLoss`	$33.40M	USD	1 Quarter
Net earnings	`ProfitLoss`	$119.62M	USD	1 Quarter
Net earnings	`ProfitLoss`	$124.94M	USD	3 Qtrs
Net earnings	`ProfitLoss`	$46.14M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$61.75M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$63.08M	USD	3 Qtrs
Costs recognized on sale of acquired inventory	`FairValueWriteUpOfAcquiredInventory`	-	USD	3 Qtrs
Costs recognized on sale of acquired inventory	`FairValueWriteUpOfAcquiredInventory`	$91.00K	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-6.02M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$8.64M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$39.17M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$26.35M	USD	3 Qtrs
Contingent consideration payments	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-155.00K	USD	3 Qtrs
Contingent consideration payments	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	-	USD	3 Qtrs
Fair value adjustment to contingent consideration payable	`FairValueAdjustmentToContingentConsiderationPayable`	$6.19M	USD	3 Qtrs
Fair value adjustment to contingent consideration payable	`FairValueAdjustmentToContingentConsiderationPayable`	$-605.00K	USD	3 Qtrs
Fair value adjustment on available for sale investments	`FairValueAdjustmentOnAvailableForSaleSecurities`	$10.23M	USD	3 Qtrs
Fair value adjustment on available for sale investments	`FairValueAdjustmentOnAvailableForSaleSecurities`	$-111.27M	USD	3 Qtrs
Leases, net	`NoncashPortionOfLeaseExpense`	$191.00K	USD	3 Qtrs
Leases, net	`NoncashPortionOfLeaseExpense`	$83.00K	USD	3 Qtrs
Other operating activity	`OtherOperatingActivitiesCashFlowStatement`	$-865.00K	USD	3 Qtrs
Other operating activity	`OtherOperatingActivitiesCashFlowStatement`	$-608.00K	USD	3 Qtrs
Trade accounts and other receivables, net	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-2.69M	USD	3 Qtrs
Trade accounts and other receivables, net	`IncreaseDecreaseInAccountsAndOtherReceivables`	$32.71M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$4.12M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$10.01M	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-414.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$2.00M	USD	3 Qtrs
Trade accounts payable, accrued expenses, contract liabilities, and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$10.03M	USD	3 Qtrs
Trade accounts payable, accrued expenses, contract liabilities, and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$12.20M	USD	3 Qtrs
Salaries, wages and related accruals	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-5.09M	USD	3 Qtrs
Salaries, wages and related accruals	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$13.83M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$3.53M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$10.15M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$160.43M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$230.14M	USD	3 Qtrs
Proceeds from sale and maturities of available-for-sale investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$66.38M	USD	3 Qtrs
Proceeds from sale and maturities of available-for-sale investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$122.67M	USD	3 Qtrs
Purchases of available-for-sale investments	`PaymentsToAcquireAvailableForSaleSecurities`	$39.68M	USD	3 Qtrs
Purchases of available-for-sale investments	`PaymentsToAcquireAvailableForSaleSecurities`	$50.73M	USD	3 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$32.98M	USD	3 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$34.37M	USD	3 Qtrs
Investment in unconsolidated entity	`InvestmentInUnconsolidatedEntity`	$556.00K	USD	3 Qtrs
Investment in unconsolidated entity	`InvestmentInUnconsolidatedEntity`	-	USD	3 Qtrs
Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$9.77M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-16.61M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$37.57M	USD	3 Qtrs
Cash dividends	`PaymentsOfDividendsCommonStock`	$37.17M	USD	3 Qtrs
Cash dividends	`PaymentsOfDividendsCommonStock`	$36.64M	USD	3 Qtrs
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$54.99M	USD	3 Qtrs
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$38.49M	USD	3 Qtrs
Re-purchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$50.11M	USD	3 Qtrs
Re-purchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$43.18M	USD	3 Qtrs
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	3 Qtrs
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$40.00M	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLinesOfCredit`	$125.38M	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLinesOfCredit`	$141.38M	USD	3 Qtrs
Other financing activity	`ProceedsFromPaymentsForOtherFinancingActivities`	$-13.50M	USD	3 Qtrs
Other financing activity	`ProceedsFromPaymentsForOtherFinancingActivities`	$-5.44M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-180.24M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-139.08M	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-3.58M	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$6.22M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$39.51M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$55.33M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$146.62M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$186.14M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$100.89M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$156.22M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$146.62M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$186.14M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$100.89M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$156.22M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$17.96M	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	$24.85M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$14.20M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$10.73M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.